• Reporting adverse reactions to marketed health products - Guidance document for industry
• Questions and Answers Document: Ethnic Factors in the Acceptability of foreign Clinical …
• Notice: Health Canada and United States Food and Drug Administration Joint Public …
• Clarification of section 4.3 (Regulatory Authority Sources) of the Reporting Adverse Reactions …
• Notice – Release of ICH M9: Biopharmaceutics Classification System (BCS) Based Biowaivers